Provesica
Provesica is a Cambridge-based biopharmaceutical company specializing in treatments for overactive bladder syndrome.
Business Model:
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed Provesica Information
Geographic Data
Address:
City: Cambridge
State: Cambridgeshire
Zip:
Country: United Kingdom
Financial Info
Stage:
series unknown
Raised Last:
$6M
Raised Total:$6M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Provesica is a Cambridge-based biopharmaceutical company specialising in overactive bladder. The Company’s development compound, XEN-D0501, is highly potent antagonist of the vanilloid receptor, TRPV1, and is about to start Phase 2 clinical development. In addition to XEN-D0501, Provesica owns a portfolio of intellectual property covering diverse TRPV1 antagonists suitable for development in overactive bladder or other indications where TRPV1 has been validated as an intervention target. Provesica was established in 2010 following the demerger of the overactive bladder and TRPV1 interests of Xention Ltd, an ion channel specialist drug discovery and development company. Provesica has so far raised £4 million in finance to progress its lead programme through Phase 2 development.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 12/2010 | Venture Round | 1 | $6.2M |
Seroba Life Sciences Seroba Life Sciences |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
